Skip to main content
Caplight Logo









Synaptiq

Synaptiq

Private
Cluj-NapocaHealthcare & Life Scienceshttps://synaptiq.io/

Last Round

Late Seed

Jul 6, 2026

Est. Valuation

$5.85M

Total Funding Raised

$1.26M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Synaptiq is a healthcare technology company that develops AI-powered software to automate the contouring of tumors and organs at risk for radiotherapy treatment planning.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

radiotherapy planningauto-contouringmedical AIradiation oncologyAI segmentationsoftware as a medical deviceSaMDclinical workflow automationmedical imaging softwareradiology AItumor delineationhealthtech SaaSPACS integrationdeep learning healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Synaptiq Comparables

Compare Synaptiq with similar companies based on industry and business-model similarity.

Synaptiq comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MVision AI
89%
TheraPanacea
88%
Oncosoft
86%

Synaptiq Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Late SeedJul 6, 2026
AcceleratorApr 23, 2026
GrantDec 20, 2023
SeedApr 4, 2023
GrantAug 29, 2022
Pre Seed
Oct 19, 2021

Key People

Founding team and executive leadership

Roxana Vesa

Co-Founder & Chief Administrative Officer

Founding Team

Dragos Duse

Chief Executive Officer

Executive Team

Synaptiq Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 81% MoM, from 3.4K to 6.2K.

  • Jul 25, 2026

    Monthly visitors increased 149% MoM.

Recent news

Latest coverage and updates

  • attends_eventJun 22, 2026

    Synaptiq Technologies S.R.L. attended event ESTRO 2026 Congress on May 15th '26.

Synaptiq Filings

Explore SEC and related filing metadata, where available.

Synaptiq filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Synaptiq's valuation, stock price, and market status.

Is Synaptiq a public or private company?

Synaptiq is a private company.

What is the current stock price of Synaptiq?

Synaptiq is a private company with no public stock price. No recent secondary market data is available.

How much is Synaptiq worth (valuation)?

Synaptiq's valuation is estimated at $5.8M based on funding round data.

Can I buy Synaptiq stock?

Synaptiq shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Synaptiq's last funding round?

Synaptiq's most recent funding round was Grant on April 4, 2023.

Who are the main investors in Synaptiq?

Key investors in Synaptiq include Fortech Investments.

Will Synaptiq IPO soon?

No public IPO plans have been announced for Synaptiq.

How can I track Synaptiq secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Synaptiq's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCluj-Napoca
Employee Range17
Year Founded2020
Last FundingJul 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?